Carfilzomib公司
医学
养生
内科学
重症监护医学
梅德林
儿科
肿瘤科
同情性使用
外科
作者
Magdalena Olszewska‐Szopa,Anna Czyż,Maria Węgrzyn,Tomasz Wróbel
摘要
In real-world clinical practice, the Kd-70 regimen demonstrated an ORR comparable to that observed in the A.R.R.O.W. trial. However, the CR and VGPR rates were lower. These findings underscore the need for further investigation into factors influencing treatment outcomes in this patient population.
科研通智能强力驱动
Strongly Powered by AbleSci AI